$PFE Headlines 10 stocks for the U.S. economy’s revival

New Post Public Reply Private Reply Replies (0) Message Board

Dec 29, 2013 at 9:56 AM

$PFE Headlines

10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch

Hold the Sizzle - Michael Price's Low P/E Stocks in Review 8:30 p.m. Dec. 28, 2013 - GuruFocus.com
Merck Plans Radical Overhaul of Drug R&D Unit 5:20 p.m. Dec. 27, 2013 - WSJ.com
Three S&P 500 and Dow Industrial Companies Report Dividend Growth and Buyback Extensions 5:20 p.m. Dec. 27, 2013 - GuruFocus.com
Is There Still Room To Profit With Halozyme? 12:52 p.m. Dec. 27, 2013 - Seeking Alpha
Best Stocks for 2014 12:39 a.m. Dec. 27, 2013 - Barrons.com
Pfizer Becomes #22 Most Shorted Dow Stock, Replacing Goldman Sachs Group 11:17 a.m. Dec. 26, 2013 - TheStreet.com
A Strong Sign for 2014 – Capital Spending vs Buybacks 4:00 a.m. Dec. 26, 2013 - InvestorPlace.com
Companies Binge on Share Buybacks 9:31 p.m. Dec. 25, 2013 - WSJ.com
Dividends: Big Dogs, Small Dogs And Spy Dogs 4:11 a.m. Dec. 25, 2013 - Seeking Alpha
Pipeline Progress at Athersys - Analyst Blog 5:20 p.m. Dec. 24, 2013 - Zacks.com
Update on Glaxo's HIV Drugs - Analyst Blog 4:30 p.m. Dec. 24, 2013 - Zacks.com
AT&T and Pfizer Top GuruFocus Dividend Growers of the Week 11:28 a.m. Dec. 24, 2013 - GuruFocus.com
Where Will GlaxoSmithKline Go Next? 10:50 a.m. Dec. 24, 2013 - Wall St. Cheat Sheet
Dow Dogs Drink To A Dominant 2013. Will They Toast A Triumphant 2014, Too? 10:38 a.m. Dec. 24, 2013 - Seeking Alpha
Capital Spending vs. Buybacks - Ahead of Wall Street 9:59 a.m. Dec. 24, 2013 - Zacks.com
Genetic Technologies updates patent program, grants license 8:19 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
Dow Today: Pfizer (PFE) Higher 2:00 p.m. Dec. 23, 2013 - TheStreet.com
21 Stocks Giving the Gift of Dividend Growth 11:23 a.m. Dec. 23, 2013 - GuruFocus.com
Flush Coffers, Fat Payouts 2:34 a.m. Dec. 21, 2013 - Barrons.com

Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth 8:00 a.m. Dec. 20, 2013 - PR Newswire
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
Athersys Confirms Completion of Patient Enrollment of Pfizer's Phase II Study of MultiStem(R) Cell Therapy for Ulcerative Colitis 7:00 a.m. Dec. 19, 2013 - GlobeNewswire
Surgical Scar Market Is Ripe for Innovation 11:15 a.m. Dec. 18, 2013 - ACCESSWIRE
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
Teva Settles Viagra(R) Patent Litigation with Pfizer 4:35 p.m. Dec. 17, 2013 - BusinessWire
Pfizer Settles Viagra(R) Patent Litigation With Teva 11:55 a.m. Dec. 17, 2013 - BusinessWire
Pfizer Invites Public To View And Listen To Webcast Of January 28 Conference Call With Analysts 10:00 a.m. Dec. 17, 2013 - BusinessWire
Pfizer Names Albert Bourla Group President; Vaccines, Oncology and Consumer Healthcare Business 9:00 a.m. Dec. 17, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Pfizer Declares First-Quarter 2014 Dividend 11:20 a.m. Dec. 16, 2013 - BusinessWire
InvestorsObserver releases comments on Pfizer, Oracle, FedEx, Jabil Circuit, and Trulia 9:31 a.m. Dec. 16, 2013 - PR Newswire
Siemens Enters Into Master Agreement With Pfizer for Companion Diagnostics 9:26 a.m. Dec. 16, 2013 - BusinessWire
Critical Alerts For Pfizer, Halliburton, Joy Global, Anadarko Petroleum, and Hewlett Packard Released By InvestorsObserver 9:31 a.m. Dec. 12, 2013 - PR Newswire
Octapharma AG Enters into Agreement with Pfizer for the Future Commercialization and Marketing in the U.S. of an Investigational Intravenous Therapy for the Urgent Reversal of an Oral Anticoagulant 8:59 a.m. Dec. 11, 2013 - BusinessWire
Octapharma AG Enters into Agreement with Pfizer for the Future Commercialization and Marketing in the U.S. of an Investigational Intravenous Therapy for the Urgent Reversal of an Oral Anticoagulant 6:00 a.m. Dec. 11, 2013 - BusinessWire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
New Clinical Data Access Policy, Portfolio Expansions, Positive Top Line Results and Stock Price Movements - Research Report on Pfizer, Amgen, Puma Biotechnology, Abbott Laboratories, and Agilent 8:00 a.m. Dec. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Red Banyan Earns Top Honors in Florida for 2026

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

ScholarShare 529 Launches $50 Back-to-School Promo

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Solar Fencing Revolutionizes North Texas Homes

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Koogler's Sale to ALL4: A Game-Changer for the Southeast

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Ransoms and Mega-Losses Surge in Cyber Claims Study

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Medicare Competitive Bidding May Slash Jobs, Access

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Lyric Health's AI System Promises Data-Driven Revolution

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Goddess Maintenance Co. Eyes BeautyMatter Award

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...